Recorded Chinese product: 羟苯磺酸钙片羟苯磺酸钙片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 南京长澳制药有限公司Chinese legal name: 南京长澳制药有限公司
药物知识说明
羟苯磺酸钙一水合物是一种在国家药监局注册认定的药品。标注生产企业为南京长澳制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：南京长澳制药有限公司Chinese legal name: 南京长澳制药有限公司、南京长澳制药有限公司Chinese legal name: 南京长澳制药有限公司、南京长澳制药有限公司Chinese legal name: 南京长澳制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 羟苯磺酸钙片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 南京长澳制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 南京长澳制药有限公司Chinese legal name: 南京长澳制药有限公司, 南京长澳制药有限公司Chinese legal name: 南京长澳制药有限公司, 南京长澳制药有限公司Chinese legal name: 南京长澳制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 羟苯磺酸钙片Recorded Chinese product: 羟苯磺酸钙片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.5g*20片0.5 g × 20 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 南京长澳制药有限公司Chinese legal name: 南京长澳制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20030087
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20030087
Manufacturer
Chinese legal name: 南京长澳制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
0.5 g × 20 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H20030087
生产企业
南京长澳制药有限公司(国产)
适应症
主要用于糖尿病引起的视网膜病变和肾小球性硬化症。也用于微循环障碍引起的各种静脉曲张和痔疮、溃疡腿、瘙痒性皮炎等。
用法用量
口服用药应个体化。用于严重微血管病变，初始剂量为1.5～2g/日，维持量为1g/日；用于微循环机能不全者，一般1g/日，大多数患者3周为一疗程，可视病情而定。
不良反应
偶见胃部不适、恶心、胃灼热、食欲缺乏等症状；此时，应酌情减量，必要时暂停给药。
禁忌
对本品过敏者禁用。
注意事项
1．使用本品需结合降糖药进行治疗，第一次使用本品前应咨询医师。
2．治疗期间应定期到医院检查。
3．妊娠前3个月及哺乳期妇女不推荐使用。
4．当本品性状发生改变时禁止服用。
5．儿童必须在成人监护下使用。
6．请将此药品放在儿童不能接触的地方。
贮藏
遮光，密闭保存。
规格
0.5g*20片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.